The motion
sickness treatment market has evolved steadily over the years driven
by expanding scope of pharmacologic therapy. Growing array of medications used
in pharmacotherapy to alleviate the symptoms of motion sickness has underlined
the lucrativeness quotient for both over-the-counter (OTC) drug makers and
prescription drug producers. Particularly, the conspicuous presence of OTC drug
manufacturers in developed as well as emerging markets has resulted in a highly
fragmented landscape. This has changed the dynamic of competition among the
ecosystem of OTC and prescription drug makers in the motion sickness treatment
market, notes Transparency Market Research (TMR).
Over the past few years, clinicians and the
healthcare industries have gained better understanding of the pathophysiology
of motion sickness, thereby helping share the varied contours of the motion
sickness treatment market. A growing body of clinical studies that evaluate
recent drug interventions on the underlying symptoms have been instrumental in
broadening the scope of treatments, world over. A range of drug therapies have
hit the motion sickness treatment market; however, the adverse side effects are
crucial for the medical and patient communities.
Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39320
New Generation of Drugs Aim at Reducing Side-Effects
A fast emerging category is
anticholinergics, particularly scopolamine, in the motion sickness treatment
market. The uptake of anticholinergics in the form of transdermal scopolamine
patches has been gathering traction in the market. The anticholinergics segment
is expected to hold at least half of the share of the global market during the
assessment period. Of note, research and development activities pertaining to
the commercialization of intranasal scopolamine are likely to change the future
course of the market substantially.
On the other hand, second-generation
antihistamines are gathering steam as OTC drug for alleviating or substantially
ameliorating the symptoms of motion sickness such as vertigo, nausea, and
vomiting. They are being considered clinically better than first-generation
ones due to their ability to work via peripheral versus central receptors.
However, an assortment of first generation antihistamines are available over
the counter and a few have been approved by the FDA for indications in children
and adults.
Request customization on Motion Sickness
Treatment Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=39320
Still, pediatric remains a challenging
category for drug manufacturers tapping into the prevailing opportunities in
the market. Further, a range of components with possible antihistaminergic
effect have been intensively studied, expanding the avenues for growth of the
motion sickness treatment market.
Understanding Use of Symptom Inducing Tech
to Drive Future Research in Emerging Markets
Asia Pacific among all regions is emerging
as a market with immense potential. The regional market is anticipated to gain
shares substantially with the strides the global motion sickness treatment
market in the next five years span. Growing penetration of prescription motion
sickness drugs among a fast growing numbers of travelers has been fueling its growth.
Developed markets, particularly North America, have prospered on the back of
large uptake of high-cost prescription drugs. On the other hand, the advent of
generic transdermal scopolamine patches will shape the revenue generation of
various key regions in the motion sickness treatment market.
Buy Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=39320<ype=S
Rapidly rising use of information
technology and virtual reality representations and modern simulation systems
that induce motion sickness have considerably shaped our understanding of the
etiology of the disease. Tellingly, this will help researchers test new drug
intervention approaches. A case in point is neuropharmacological investigations
gathering steam among the research community.
Read
More Information:
https://www.transparencymarketresearch.com/pressrelease/motion-sickness-treatment-market.htm
Browse more Market Reports:
Life Sciences Tools Market:
https://www.transparencymarketresearch.com/life-sciences-tools.html
Analgesics Market:
https://www.transparencymarketresearch.com/analgesics-market.html
Respiratory Pathogen Testing Market:
https://www.transparencymarketresearch.com/respiratory-pathogen-testing-market.html
About Us:
Transparency Market Researchis a global market intelligence company, providing global business information
reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for thousands of decision
makers. Our experienced team of Analysts, Researchers, and Consultants, use
proprietary data sources and various tools and techniques to gather, and
analyse information. Now avail flexible Research Subscriptions, and access
Research multi-format through downloadable databooks, infographics, charts,
interactive playbook for data visualization and full reports through MarketNgage,
the unified market intelligence engine. Sign Up for
a 7 day free trial!
Contact
Us
Mr.
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
The Wall